Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FK38E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,874
Award facts
- Contract value 100% obligated
- $32,874.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,874.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Stelara 45 mg/0.5 ml syringes. The contract is non-set-aside and carries an ultimate completion date of September 4, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle that extends through December 2026 and enables the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts reflects its capability to competitively supply diverse pharmaceutical products spanning multiple therapeutic domains, from specialty medications and vaccines to medical devices and specialized healthcare commodities. This delivery order for Stelara, a biologic medication used for immunological conditions, represents a routine fulfillment under the established prime IDC vehicle, demonstrating the contractor's ongoing role in supporting military medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DB25FK38E?
SPE2DB25FK38E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FK38E worth?
The government has obligated $32,874 on SPE2DB25FK38E.
Is contract SPE2DB25FK38E an order under another contract?
Yes. SPE2DB25FK38E is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK38E competed?
The extent of competition for SPE2DB25FK38E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award